{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:16:25Z","timestamp":1793718985460,"version":"4.6.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Prior studies have identified that vancomycin resistant enterococcus (VRE) bacteremia that persists for four days or more is an independent predictor of mortality. Despite this, there is no published data to identify those patients at highest risk of developing persistent VRE bacteremia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a single center, retrospective, case-control study of adult patients with a VRE bloodstream infection (BSI). Case patients were those with persistent bacteremia (\u2265\u20094 days despite VRE-directed therapy) and control patients were those with non-persistent bacteremia. Logistic regression was used to assess risk factors associated with persistent VRE BSIs. Secondary outcomes included in-hospital mortality, recurrent bacteremia, and breakthrough bacteremia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During the study period, 24\/108 (22%) patients had persistently positive blood cultures. Risk factors for persistent bacteremia included severe neutropenia (OR 2.13), 4 out of 4 positive index blood cultures (OR 11.29) and lack of source control (OR 11.88). In an unadjusted analysis, no statistically significant differences in in-hospital mortality (58% versus 40%; p\u2009=\u20090.121), recurrent bacteremia (17% versus 6%; p\u2009=\u20090.090), or breakthrough bacteremia (13% versus 7%; p\u2009=\u20090.402) were observed between groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Patients with severe neutropenia, 4 out of 4 positive index blood culture bottles, and lack of source control were more likely to develop persistent VRE bacteremia despite directed antibiotic treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07864-8","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T16:03:52Z","timestamp":1668614632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia"],"prefix":"10.1186","volume":"22","author":[{"given":"Emily","family":"Fox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bounthavong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Mui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Holubar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Deresinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Alegria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"key":"7864_CR1","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/cid\/cis550","volume":"55","author":"J Vydra","year":"2012","unstructured":"Vydra J, et al. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2012;55:764\u201370.","journal-title":"Clin Infect Dis"},{"key":"7864_CR2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/clinids\/20.2.296","volume":"20","author":"GA Noskin","year":"1995","unstructured":"Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis Bacteremia: acquisition and outcome. Clin Infect Dis. 1995;20:296\u2013301.","journal-title":"Clin Infect Dis"},{"key":"7864_CR3","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1086\/339211","volume":"34","author":"P Thomas","year":"2002","unstructured":"Thomas P, Peggy L, Vincent HT, Rybak MJ. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center. Clin Infect Dis. 2002;34:922\u20139.","journal-title":"Clin Infect Dis"},{"key":"7864_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ijid.2014.02.012","volume":"26","author":"EO Billington","year":"2014","unstructured":"Billington EO, Incidence, et al. Risk factors, and outcomes for Enterococcus spp. blood stream infections: a population-based study. Int J Infect Dis. 2014;26:76\u201382.","journal-title":"Int J Infect Dis"},{"key":"7864_CR5","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1093\/cid\/ciw110","volume":"62","author":"EJ Zasowski","year":"2016","unstructured":"Zasowski EJ, Claeys KC, Lagnf AM, Davis SL, Rybak MJ. Time is of the essence: the impact of delayed antibiotic therapy on patient outcomes in hospital-onset enterococcal bloodstream infections. Clin Infect Dis. 2016;62:1242\u201350.","journal-title":"Clin Infect Dis"},{"key":"7864_CR6","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jmii.2017.08.025","volume":"51","author":"J-J Ye","year":"2018","unstructured":"Ye J-J, et al. Clinical characteristics and treatment outcomes of vancomycin-resistant Enterococcus faecium bacteremia. J Microbiol Immunol Infect. 2018;51:705\u201316.","journal-title":"J Microbiol Immunol Infect"},{"key":"7864_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/430909","volume":"41","author":"CA DiazGranados","year":"2005","unstructured":"DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis. 2005;41:327\u201333.","journal-title":"Clin Infect Dis"},{"key":"7864_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab616","author":"GA Contreras","year":"2021","unstructured":"Contreras GA, et al. Contemporary clinical and molecular epidemiology of vancomycin-resistant enterococcal bacteremia: a prospective multicenter cohort study (VENOUS I). Open Forum Infect Dis. 2021. https:\/\/doi.org\/10.1093\/ofid\/ofab616.","journal-title":"Open Forum Infect Dis."},{"key":"7864_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1\u201345.","journal-title":"Clin Infect Dis"},{"key":"7864_CR10","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s41598-018-19986-8","volume":"8","author":"Y-C Chuang","year":"2018","unstructured":"Chuang Y-C, et al. A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections. Sci Rep. 2018;8:1632.","journal-title":"Sci Rep"},{"key":"7864_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0732-8893(99)00136-4","volume":"36","author":"SM Bhavnani","year":"2000","unstructured":"Bhavnani SM, et al. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis. 2000;36:145\u201358.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"7864_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/MD.0b013e318289ff1e","volume":"92","author":"YP Chong","year":"2013","unstructured":"Chong YP, et al. Persistent Staphylococcus aureus bacteremia: a prospective analysis of risk factors, outcomes, and microbiologic and genotypic characteristics of isolates. Med (Baltim). 2013;92:98\u2013108.","journal-title":"Med (Baltim)"},{"key":"7864_CR13","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1097\/CCM.0000000000003325","volume":"46","author":"S Kanjilal","year":"2018","unstructured":"Kanjilal S, Kalil AC, Klompas M. What is the best treatment for vancomycin-resistant enterococcal bloodstream infections?*. Crit Care Med. 2018;46:1700\u20133.","journal-title":"Crit Care Med"},{"key":"7864_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/1060028014556879","volume":"49","author":"R Patel","year":"2015","unstructured":"Patel R, Gallagher JC. Vancomycin-resistant enterococcal bacteremia pharmacotherapy. Ann Pharmacother. 2015;49:69\u201385.","journal-title":"Ann Pharmacother"},{"key":"7864_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1586\/14787210.2015.1001839","volume":"13","author":"KE Barber","year":"2015","unstructured":"Barber KE, King ST, Stover KR, Pogue JM. Therapeutic options for vancomycin-resistant enterococcal bacteremia. Expert Rev Anti-infective Therapy. 2015;13:363\u201377.","journal-title":"Expert Rev Anti-infective Therapy"},{"key":"7864_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.idc.2016.02.006","volume":"30","author":"WR Miller","year":"2016","unstructured":"Miller WR, Murray BE, Rice LB, Arias CA. Vancomycin-resistant enterococci: therapeutic challenges in the 21st century. Infect Dis Clin North Am. 2016;30:415\u201339.","journal-title":"Infect Dis Clin North Am"},{"key":"7864_CR17","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"key":"7864_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, et al. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381.","journal-title":"J Biomed Inform"},{"key":"7864_CR19","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/03610928008827941","volume":"9","author":"DW Hosmer","year":"1980","unstructured":"Hosmer DW, Lemesbow S. Goodness of fit tests for the multiple logistic regression model. Commun Stat Theory Methods. 1980;9:1043\u201369.","journal-title":"Commun Stat Theory Methods"},{"key":"7864_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0732-8893(99)00136-4","volume":"36","author":"SM Bhavnani","year":"2000","unstructured":"Bhavnani SM, et al. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia\u2606. Diagn Microbiol Infect Dis. 2000;36:145\u201358.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"7864_CR21","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ajic.2010.07.014","volume":"39","author":"JT Freeman","year":"2011","unstructured":"Freeman JT, Chen LF, Sexton DJ, Anderson DJ. Blood culture contamination with Enterococci and skin organisms: implications for surveillance definitions of primary bloodstream infections. Am J Infect Control. 2011;39:436\u20138.","journal-title":"Am J Infect Control"},{"key":"7864_CR22","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1086\/657583","volume":"31","author":"DJ Sexton","year":"2010","unstructured":"Sexton DJ, Chen LF, Anderson DJ. Current definitions of central line\u2013associated bloodstream infection is the emperor wearing clothes? Infect Control Hosp Epidemiol. 2010;31:1286\u20139.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"7864_CR23","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/S1473-3099(20)30447-3","volume":"20","author":"R Kuehl","year":"2020","unstructured":"Kuehl R, et al. Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study. Lancet Infect Dis. 2020;20:1409\u201317.","journal-title":"Lancet Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07864-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07864-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07864-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T16:05:19Z","timestamp":1668614719000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07864-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7864"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07864-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"assertion":[{"value":"12 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Stanford University School of Medicine Panel on Human Subjects in Medical Research and deemed to be non-human research. This study used retrospective data, which was collected as part of routine clinical practice; therefore, the requirement for informed consent was waived. All methods were performed in accordance with local guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"855"}}